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Background: The acute inhalation of endotoxin mimicks several aspects of the inflammation related to chronic
obstructive pulmonary disease (COPD). The aim of the current study was to identify and to validate biomarkers of
endotoxin-induced airways’ inflammation.
Methods: The cellular count in the induced-sputum, was measured before and after an inhalation of 20 mcg
endotoxin, in 8 healthy volunteers. A proteomic analysis was applied to identify the more relevant proteins
expression, before measurement by ELISA. The amplitude and the repeatability of the markers were evaluated
among another population of 12 healthy subjects.
Results: There was a significant rise of viable cells (p <0.01), macrophages (p <0.05), and neutrophils (p <0.02)
24 hours after endotoxin inhalation, and of neutrophils (p <0.02) and lymphocytes (p <0.05) at 6 hours. Among the
highest amplitude responses, the two dimensional electrophoretic separation shown proteolytic activity and
overexpression of protein spots. By MALDI-TOF mass spectrometry, the last were identified as calgranulin A and B.
The expression of the bioactive A/B heterodimeric complex was confirmed by ELISA both in the sputum (p <0.01)
and at the blood level (p <0.01). The intra-subject repeatability of the sputum calgranulin A/B was highly significant
(p <0.0001).
Conclusion: In healthy subjects, the inhalation of endotoxin induced expression of sputum calgranulin A/B that
could be a biomarker of the endotoxin response/exposure.
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Endotoxin and its purified derivative lipopolysaccharide
(LPS) are pro-inflammatory constituents from Gram-
negative bacteria, present in a variety of occupational
and home environments [1] and in cigarette smoke [2].
In the airways, LPS is signalling through the Toll-like
receptor-4 (%TLR4), expressed by the stromal cells of
the lung [3].
In healthy subjects, an acute inhalation of LPS produces
fever and flu-like symptoms, a rise of sputum polymorpho-
nuclear neutrophils (sPMN) and inflammatory mediators,* Correspondence: omichel@ulb.ac.be
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reproduction in any medium, provided the ora blood increase and activation of neutrophils and an in-
crease of the C-reactive protein (CRP) [4-6]. It was pro-
posed that this inflammatory response could be a model
to evaluate anti-inflammatory drugs [7-10]. However the
limitation is the large inter- and intra-subject variation of
the amplitude of the response [11,12], due to both genetic
factors and methods to measure the inflammatory re-
sponse [13]. One important factor of variation is the saliva
contamination during the plugs selection. To improve the
strength of the LPS model, there is a need for a valid bron-
chial inflammatory marker, in regard with the neutrophilc
activation.
In the present study, larger responders to LPS inhal-
ation were selected among a group of healthy subjects.
Instead of measurement of a number of markers of cellsLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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possible markers of the lung injury among the selected
subjects and to evaluate the saliva contamination. Then,
the highlighted biomarkers were measured by ELISA
among all the subjects. Afterwards, the repeatability of
the biomarker was evaluated in both sputum and serum.
Methods
Subjects
Population A. Nine healthy non smoker volunteers of
age 18–50 were able to produce an adequate induced-
sputum (defined as viability of > 70%, squamous cells
< 50% and a percentage of PMN < 50%). The reason to
select subjects with a low basal inflammation (< 50%
PMN) was to increase the chance to observe a larger in-
flammatory response to LPS, before proteomic analysis.
One subject having declined to participate to the LPS
challenge, eight subjects (subjects 1 to 8) were included
(36.7 (± 2.4) years; F/M = 4/4). The study was approved,
by the Ethical Committee (decision number 04-03-7/
2617 of the National Register) of the Institution (CHU
St-Pierre).
Population B. A second population of 12 healthy non
smoker volunteers (subjects 9 to 20) was included (37.2
(±2.3) years; F/M = 9/3). They were able to produce an
adequate induced-sputum without limits of the % of
PMN. The study was approved by the Ethical Commit-
tee (decision CE2010/09 13-01-2010) of the Institution
(CHU Brugmann).
Informed written consent was obtained in each subject
from both populations.
General design
On day 0, a sputum was induced (defined as basal spu-
tum) among the subjects of population A. On days 14
and 28, each subject was exposed to LPS by inhalation.
An induced-sputum was sampled at 6 or 24 hours, in
random order, after each LPS exposure. By doing so, we
avoided an interference of saline [14] and repeated LPS
inhalations [15] on the response to LPS. The procedure
of LPS challenge has been previously reported [4,12].
Briefly 20 μg of a suspension of LPS (Escherichia coli
026:B6 from Sigma Chemical, St Louis, MO -ref L-2654)
was administered by a Mefar dosimeter MB3 (Mefar,
Brescia, Italy). Symptoms, oral temperature, forced vital
capacity (FVC), forced expiratory volume in 1 second
(FEV1) and the FEV1/FVC were recorded before and
hourly after LPS.
In the 2d part of the study, the population B was chal-
lenged with inhaled LPS. The blood was sampled before,
6 and 24 hours after LPS, while the sputum were in-
duced 7 days before and 24 hours after the LPS chal-
lenge. To evaluate the reproducibility of the response,
the LPS challenges were repeated after a 2 weeks ofwash-out. This period is enough, since we have shown
previously that the LPS induced sputum inflammation
normalized after 7 days [15]. The mean of each param-
eter was calculated.
Induced sputum
Hypertonic sterile saline (5%) was nebulized for 30 mi-
nutes with an ultrasonic nebulizer (Fisoneb; Karapharm,
Marseille, France); subjects rinsed their mouth with
water every 10 minutes and tried to cough sputum dir-
ectly into a sterile plastic box. After selection of all por-
tions of sputum as free as possible of saliva [16], the
plugs were weighed, mixed with 4 volumes of dithiotrei-
tol 0.1% (Sputolysin; Behring Diagnostics, Somerville,
NJ), homogenised and rocked for 15 min. before adding
4 volumes of Dulbecco’s PBS. After filtration and centri-
fugation (15 minutes at 800 g) the supernatant was fro-
zen at -80°C while the pelleted cells were resuspended in
PBS. The number of total cells was measured with a
Thoma’s hemocytometer. The cell viability was assessed
by the Trypan blue method. A slide was prepared by
centrifugation (Cytospin, Shandon Inc, Pittsburgh, PA)
and stained with May-Grünwald-Giemsa. The percent-
age of the cells were counted on a total of 400 cells.
Proteomic analysis of the sputum
Prior to two dimensional electrophoretic separation, su-
pernatants of sputa were extensively dialysed against
rehydratation buffer (8 M urea, 2% (w/v) CHAPS, phar-
malyte 2% (v/v) and 50 mM DTT). 50 μg of proteins
were then subjected to isoelectric focusing on immobilized
pH gradient (IPG) strips (pH 3–10; NL; 18 cm; Amersham
Pharmacia Biotech, Sweden). The first-dimension isoelec-
tric focusing was carried out as previously described [17].
For the second dimension, thin precast horizontal gels
(ExcelGel XL SDS 12–14, Amersham Biosciences) were
run for three hours at 40 mA. Gels were stained with a
mass spectrometry compatible silver staining procedure as
described previously [17].
Proteins identification
The silver-stained protein spots of interest (taking into
account the intensity and repeatability of the spots) were
cut out and distained by incubation of gel pieces in
200 μl of 0.003 mM K4[Fe(CN)6], 0.01 mM Na2S2O3 for
15 minutes. Gel pieces were then washed twice in
25 mM NH3HCO3 for 15 minutes under gentle agitation
at room temperature, followed by two 15 minutes
washes in 25 mM NH3HCO3, 50% (v/v) CH3CN. After
Speed vacuum dehydration, 10 μl of a 0.02 μg/μl trypsin
solution in 25 mM NH3HCO3 (Promega Madison), were
added, and samples were incubated overnight at 37°C.
Tryptic digestion was stopped by addition of 1 μl of 5%
(v/v) formic acid. For MALDI-TOF analysis, 1 μl of each
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ano-4-hydroxycinnamic acid and 0.5 pmol/μl rennin as
internal standard, in 25% (v/v) ethanol, 25% (v/v) aceto-
nitrile, 0.05% (v/v) TFA), then spotted onto a MALDI
sample plate and allowed to air dry. MALDI-TOF was
performed using a M@ldi™ mass spectrometer (Micro-
mass, Manchester, UK) equipped with a 337 nm nitro-
gen laser. The instrument was operated in the positive
reflectron mode with 15 kV of source voltage, 2.5 kV of
pulse voltage and 2 kV of reflecting voltage. Proteins
identification was realized using ProteinLynx global ser-
ver (Micromass) in Swiss-prot (release 54.2) and
TREmBL (release 37.0) database without species restric-
tion, using mass tolerance of 100 ppm, carbamidometh-
ylation of Cysteine as fixed modification and oxidation
of methionine as variable modification.
Calgranulin assays in sputa and sera
Due to the presence of large amount of reducing agent,
sputa were extensively dialysed against 50 mM Tris–HCl
pH 7.4 at 4°C before calgranulin assay by ELISA. Calgra-
nulin A and B and calgranulin A/B complex, were assayed
in sputa (from population A) using the calgranulin A and
B assay kits from DPC (USA), and the calgranulin assay
kit from BMA biochemical (CH), respectively, following
manufacturer instructions. Calgranulin A/B complex was
assayed in sera and sputa of population B, using the cal-
granulin assay kit from BMA biochemical (CH, product
code: S-1011). The lower limit of sensitivity of the assay is
20 ng/mL. Sputa were tested undiluted.
Interferon-gamma (IFN), Interleukin-6 (IL-6) and
interleukin-8 (IL-8) assays in sputa
The concentrations of IL-6, IL-8 and IFN in the superna-
tants of the sputa were measured by flow cytometry, using
the Cytometric Bead Array Human Inflammatory Kit from
BD Biociences (San Jose, CA), with a theoretical limit of
detection 2.5 pg/mL for IL-6 and 3.6 pg/mL for IL-8.
Statistics
The data were expressed as means ± SE, after log trans-
formation when required. Means were compared by
paired or non-paired t-tests. Repeatability was assessed
by plotting the differences between repeated measure-
ments against the mean of the repeated measures, and
testing whether the mean differences was significantly
different from 0 (method of Bland and Altman) [18]. As-
sociations were assessed by linear regression analysis. A
p value < 0.05 was considered as significant.
Results
The response to inhaled endotoxin in population A:
Except subject 4 who complained of slight fatigue and
headache, there was no significant symptom, and onresponse of lung function or fever 24 hours after LPS.
At the sputum level, the rise of log PMN was significant
6 and 24 hours after LPS, while the lymphocytes rose at
6 hours and the macrophages at 24 hours (Figure 1).
The significant rise of the total protein concentrations
(p < 0.02) and of the total viable cells (p < 0.02) into the
sputum, 24 hours after LPS, were characterized by vari-
able amplitude between the subjects (Figure 1). The
three subjects displaying the larger response (subjects 3,
6, 8) were selected to evaluate the protein content by
2DE approach.
A two dimensional electrophoretic separation was ap-
plied on the sputum supernatants. The contamination of
the sputum samples by saliva was excluded because
major salivary proteins, Cystatine S, Amylase and Lyso-
zyme, were observed on saliva gel and clearly absent in
the sputum (Figure 2). The reproducibility of sputa ana-
lysis by 2DE was tested by running three times the same
sample and analyzing, by use of PDQuest, the resulting
gels in terms of spot numbers and relative intensity for
40 randomly selected spot. There was no significant dif-
ference between these triplicates (data not shown). The
inter-individual variability has also been tested. In this
context, three sputa samples, at the basal state, from dif-
ferent subjects were analysed by 2DE. While the protein
profile and number of spots seemed very similar, the
relative intensities of 40 randomly selected spots showed
significant differences. Nevertheless, this inter-individual
variability was in the range of what is generally observed
for other biological fluids.
Compared to time 0, at times 6 and 24 hours after
PLS, a decrease in intensities of protein spots of human
serum albumin (HSA) was observed, in association with
the expression of a number of protein spots correspond-
ing to HSA fragments (shown by decrease of MW in
SDS page), suggesting the occurrence of a proteolytic ac-
tivity (Figure 3). A significant increase in two others pro-
tein spots was highlighted (Figure 3). Mass spectrometry
analysis identified these protein spots as calgranulin A
and B.
Then, the calgranulin A and B concentrations were
measured by ELISA in the sputa of all subjects of the
population. We observed an increase (though not signifi-
cant) of calgranulin A but not of calgranulin B, 24 hours
after LPS. In fact, the calgranulin A and B are secreted
as a heterodimeric complex which are not well assayed
by the ELISA for the calgranulin monomers. Consist-
ently, calgranulin A/B heterodimeric complex testing re-
vealed a significant increase in the sputum supernatant,
6 (p < 0.05) and 24 hours (p < 0.01) after LPS (Figure 4).
The response to inhaled endotoxin in population B
The mean squamous cells was 66.7 (± 21.1) cells/μL cor-




Figure 1 The sputum cells response induced by LPS. A: The mean values of the total and viable cell count. B and C: the mean changes of
the cells differential (expressed in absolute (B) and relative (C) values) before, 6 and 24 hours after LPS inhalation. D/E: The individual changes of
the total viable cell count (D) and of the concentration of proteins (E) from the sputum, before, 6, 24 hours and 7 days after LPS inhalation.
Results are expressed as means (±SE). Statistics: paired t-tests. * p > 0.05; ** p < 0.02; *** p < 0.01.
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lysis in population A. A significant neutrophilic response
with an expression of calgranulin A/B complex was con-
firmed 24 hours after LPS in the sputum (Figure 5A-B).
There was also a rise of neutrophils and calgranulin A/BFigure 2 The 2DE analysis of sputum compared to saliva. The
major salivary proteins, Cystatine S, Amylase and Lysozyme, were
observed on saliva gel and clearly absent in the sputum.complex after 6 hours at the blood level, that normalized
at 24 hours (Figure 5D-E). At the basal state, the sputum
concentration of calgranulin A/B was not correlated with
the PMN in sputum. Conversely, the LPS-induced rises of
sputum calgranulin correlated significantly (p < 0.0001)
with the rise of PMN (Figure 5C). At the blood level the
calgranulin A/B expression correlated (but less signifi-
cantly, p < 0.03) with the rise of neutrophils (Figure 5F).
The challenges were repeated at 2 weeks interval. The
Bland and Altman analysis (the differences against the
means, between the day 1 and 7) showed significant re-
peatability both for the sputum calgranulin and neutro-
philic responses. While there was a significant linear
correlation between post-LPS sputum calgranulin A/B
repeated at 2 weeks intervals, it was not significant for
the sputum post-LPS neutrophils (Figure 6). In fact, the
figure shown that the repeatability of PMN post-LPS
was related with the amplitude of the PMN response,
larger responses being less repeatable (Figure 6). The re-
peatability of both the neutrophilic and the calgranulin
responses were not significant at the blood level
(Figure 6).
The cytokines Il-6 and IL-8 increased significantly after
LPS inhalation (from 8.2 ± 2.2 to 104.7 ± 36.1 pg/mL, p < 0.02
and 800.4 ± 175.9 to 2416.2 ± 782.9 pg/mL, p < 0.05, re-
spectively). When the LPS inhalation was repeated at two
Figure 3 The 2DE analysis of LPS induced sputa. Samples collected after different recovery time (0, 6 and 24 hours) after LPS inhalation were
analyzed by 2DE and compared. This analysis clearly shows HSA degradation (A) and a rise in calgranulin A and B abundance (B and C).
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peated marker (r = 0.79 p < 0.01 and r = 0.61, p < 0.05 for
IL6 and IL8, respectively). Compared to calgranulin, the
sputum concentrations of IL6, IL8 and PMN count were
less repeatable after LPS inhalation at 2 weeks interval
(Table 1).
Discussion
An inhalation of endotoxin induced expression of the
calgranulin A/B heterodimeric complex, at the sputum
and blood levels. The rise of the sputum calgranulin A/B
complex and PMN were significantly repeatable and re-
lated, in a given subject.
Instead of measuring several inflammatory parameters,
we chose the proteomic approach to identify the end-A
Figure 4 The sputum calgranulin response induced by LPS. A: the me
before, 6 and 24 hours after endotoxin inhalation. B: the individual values o
before, 6 and 24 hours after endotoxin inhalation. Statistics: paired t-tests. *points, after having selected the subjects characterized
by a larger amplitude response. Indeed, the present
study confirmed that the changes in the cells count and
the protein concentration induced by an endotoxin in-
halation, is highly variable between subjects [8,9], this in-
dividual variability being associated with several gene
polymorphisms [19,20].
The proteomic analysis on bronchoalveolar lavage
fluid (BALF) has been used successfully for the detection
of biomarkers in COPD or cystic fibrosis [21,22]. How-
ever sampling of BALF requires bronchoscopy, an inva-
sive procedure that cannot be performed in all patients
and/or repeated in healthy subjects. Though, the tech-
nique of induced sputum can be repeated at different
time-points in a given subject. Available data haveB
an (±SE) concentrations of calgranulin A/B complex (ELISA) in sputum
f the calgranulin A/B heterodimeric complex concentration in sputum
p < 0.05, *** p < 0.01.
A B C
D E F
Figure 5 The relationship between the calgranulin and neutrophilic responses induced by LPS. The LPS-induced inflammatory response in
the 2d population. A: the significant increase of sputum calgranulin A/B complex, 24 hours after endotoxin inhalation. B: the significant rise of the
neutrophils (PMN) in the sputum, 24 hours after endotoxin inhalation. C: the linear correlation between the rises in sputum calgranulin and
sputum PMN, at 24 hours after LPS inhalation, compared to basal value. D: the significant increase of blood calgranulin A/B complex, 6 hours after
endotoxin inhalation. E: the significant increase of blood neutrophils, 6 hours after endotoxin inhalation. F: the linear correlation between the rises
in blood calgranulin and blood PMN, 6 hours after LPS inhalation, compared to basal value. Statistics: paired t-tests. *** p < 0.01, **** p < 0.001.
A B
C D
Figure 6 Assessment of repeatability of the sputum/blood calgranulin A/B and neutrophils, induced by inhaled LPS. The linear
significant correlation between post-LPS sputum calgranulin A/B repeated at 2 weeks interval, among 11 subjects (A). The absence of significant
correlation between repeated (at 2 weeks interval) post-LPS neutrophils (B), blood calgranulin (C) and blood neutrophilia (D).
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Table 1 Linear correlation of sputum biomarkers after
repeated LPS inhalation at 2 weeks interval
Sputum biomarkers n F-test r p
Calgranulin 12 77.0 0.95 < 0.0001
IL-6 12 16.3 0.79 0.0024
IL-8 12 5.7 0.61 0.0372
PMN (%) 10 4.1 0.58 0.0774
PMN (absolute value) 10 1.2 0.36 0.3051
Macrophages (absolute value) 10 0.2 0.16 0.6557
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tained by sputum-induction from healthy subjects [23];
the present data confirm that the intra- and inter-
individual repeatability of 2DE was suitable for sputum
proteome analysis and that the contamination by saliva
was not significant.
In response to endotoxin inhalation, two major phe-
nomena can be distinguished at the proteome level.
Firstly, an important proteolytic activity was suggested by
the disappearance of whole albumin and by the increase
in the amount and the number of albumin fragments on
the 2D map. Consistently, in airways inflammatory dis-
eases, the proteomic analysis identified extensive protein
degradation such as in cystic fibrosis (sputum) [22], or in
smokers with COPD (BALF) [18]. Future studies will in-
vestigate the clinical relevance of this observation. The
second endotoxin induced phenomenon is the overex-
pression of calgranulin A and B. These proteins, also
called protein S100 or MRP (myeloid-related protein), are
calcium-binding proteins involved in many regulatory ac-
tivities such as the dynamic of cytoskeleton constituents,
cell growth and differentiation, and calcium homeostasis
[24]. These two proteins were assayed in sputa after LPS
inhalation, but only confusing variation were observed in
the present study. In fact, calgranulin A and B are secreted
as the tetramer formation of S100A8/A9 [24] having bio-
logical activity [25]. Our current data showed a significant
rise in abundance both at the blood and sputum levels of
the calgranulin heterodimeric A/B complex. Consistently,
Gray et al. reported that sputum proteomics, in inflamma-
tory and suppurating respiratory diseases, identified bio-
markers such as ELISA-measured calgranulin (heterodimer
of calgranulins A and B), which is clinically relevant and
associated with the treatment [26]. Wittkowski et al. have
shown that in 8 healthy subjects (compared to subjects ex-
posed to saline), S100A12 was elevated in bronchoalveolar
lavage fluid 6 hours after LPS inhalation [27]; we extended
these data, showing that the response was measurable
both in the induced-sputum and blood and it was larger
at 24 hours, compared to 6 hours.
The induced-sputum technique allowed repeating
samples in a given subject. By doing so, we can demon-
strated that the amplitude of the endotoxin-induced riseof PMN and calgranulin A/B complex were significantly
reproducible in a given subject. Though, the LPS-
induced PMN, IL-6 and IL-8 responses were less repeat-
able. The calgranulin A/B complex rise from the non
apoptotic phagocytes is characterized by a larger ampli-
tude (increase more than 5 times) and by an immediate
diffusion into the mucus, that could explain a better re-
peatability, compared to the neutrophils.
In the present study, others soluble markers in the
sputum, such as IL-6 and IL-8 were reproducible after
repeated LPS inhalation, though with a lower signifi-
cance compared to the calgranulin. In regard with the
neutrophilic characteristics of the LPS induced inflam-
mation, this is probably due to the source of IL-6 and
IL-8 related to others cells than neutrophils such as
monocytes and lymphocytes. It is only recently, that the
question of repeatability of the LPS response has been
investigated. R Kitz et al. have published a first study
with repeated LPS challenges in human volunteers [7].
At the systemic level they reported a good repeatability
for the blood inflammatory proteins (CRP) and neutro-
philia, though there was a tendancy of rising the ampli-
tude of the response, in some subjects, after the 4th
repeated exposure. Except eNO (that did not change sig-
nificantly), there was no measurement of marker of
bronchial inflammation. In a more recent paper, O. Janssen
et al. reported a good reproducibility of sputum % of PMN
at 6 hours after an inhalation of a low dose (2 μg) LPS
[28]. Our results shown a less reproducibility of % of PMN
(r = 0.58, n = 10), that could be due to the sampling time
at 24 hours (instead of 6 hours), when the sputum % neu-
trophilia is decreasing (see Figure 1 of the present study).
They also measured MPO concentration in sputum that
was repeatable for the population as a whole [28]. While
the MPO and neutrophil elastase were not measured in
the present study, it would be an interesting comparator
in future validation experiments.
Innate immunity plays a primary role in infectious and
non-infectious diseases, which is initiated by the recog-
nition of microbial determinants, such as LPS [26]. In
concert with these pro-inflammatory substances, en-
dogenous molecules released by activated or damaged
cells, are able to activate the innate immunity mecha-
nisms. This group of molecules is called “endokines”,
“alarmins” or “damage-associated molecular patterns
(DAMP)”. One example of this substance group is the
phagocytes S100 proteins [24]. The DAMP are sensed by
the toll-like receptors (TLRs) and the receptor for ad-
vanced glycation end products (RAGE) [29]. The S100
proteins are calcium binding proteins and include more
than 20 different proteins. The S100A8 (calgranulin A or
MRP8) and S100A9 (calgranulin B or MRP14), are found
in cells of myeloid origin [30]. This is supported by the
current data showing a relationship between the LPS-
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A9 proteins, up-regulate the adhesion receptor of phago-
cytes [31], bind to endothelial cells [30], and increases
the vascular permeability [32]. Vogl et al. have demon-
strated that S100A8 interacts with the TLR4-MD2 com-
plex, which represent an endogenous ligand of TLR4,
that can amplify phagocyte activation while antibodies
against S100A8 and A9 blocked the LPS-induced phago-
cytes migration [33]. A role of calgranulin A/B complex
in the endotoxin-induced reaction is also supported by
clinical studies having related the S100A8/A9 expression
with suppuratiing respiratory diseases [26], respiratory
distress syndrome [27] and COPD [21].
In the present study, we also showed that the LPS-
induced calgranulin A/B heterodimeric complex was sig-
nificant not only in the sputum but also at the blood
level, representing a more accessible sample. However
the lack of intra-subject repeatability of this parameter
limits its potential interest.
Thus, in healthy subjects, the inhalation of endotoxin
induced a relevant and reproducible expression of spu-
tum calgranulin A/B complex. This biomarker could be
relevant to evaluate the in vivo responsiveness to inhaled
endotoxin in human.Conclusion
There is no valide and relevant measurable marker of
the inflammatory reponse to endotoxin (a promising
model to evaluate future anti-inflammatory drugs in hu-
man). By proteomic approach we identified the calgra-
nulin A/B heterodimeric complex in the sputum, and we
showed that this response was related with the neutro-
philic response, and that the repeatability was higher for
calgranulin, compared to the neutrophils. The data are
of interest for the researchers developping strategies to
evaluate drugs in their early phase of developement, in
future studies.Abbreviations
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